Logo image of IX

ORIX - SPONSORED ADR (IX) Stock Fundamental Analysis

NYSE:IX - New York Stock Exchange, Inc. - US6863301015 - ADR - Currency: USD

22.89  +0.07 (+0.31%)

Fundamental Rating

4

Overall IX gets a fundamental rating of 4 out of 10. We evaluated IX against 100 industry peers in the Financial Services industry. IX has a medium profitability rating, but doesn't score so well on its financial health evaluation. IX has a valuation in line with the averages, but it does not seem to be growing. Finally IX also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year IX was profitable.
In the past year IX had a positive cash flow from operations.
In the past 5 years IX has always been profitable.
In the past 5 years IX always reported a positive cash flow from operatings.
IX Yearly Net Income VS EBIT VS OCF VS FCFIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B -500B 1T

1.2 Ratios

Looking at the Return On Assets, with a value of 2.08%, IX is in line with its industry, outperforming 55.00% of the companies in the same industry.
The Return On Equity of IX (8.60%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 2.94%, IX perfoms like the industry average, outperforming 51.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IX is significantly below the industry average of 11.84%.
The 3 year average ROIC (2.75%) for IX is below the current ROIC(2.94%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.08%
ROE 8.6%
ROIC 2.94%
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.75%
ROIC(5y)2.57%
IX Yearly ROA, ROE, ROICIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

IX has a Profit Margin (12.23%) which is in line with its industry peers.
IX's Profit Margin has declined in the last couple of years.
The Operating Margin of IX (19.00%) is better than 66.00% of its industry peers.
IX's Operating Margin has been stable in the last couple of years.
IX's Gross Margin of 42.41% is fine compared to the rest of the industry. IX outperforms 63.00% of its industry peers.
IX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 19%
PM (TTM) 12.23%
GM 42.41%
OM growth 3Y3.42%
OM growth 5Y1.44%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
IX Yearly Profit, Operating, Gross MarginsIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IX is destroying value.
Compared to 1 year ago, IX has less shares outstanding
IX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, IX has an improved debt to assets ratio.
IX Yearly Shares OutstandingIX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
IX Yearly Total Debt VS Total AssetsIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5T 10T 15T

2.2 Solvency

IX has an Altman-Z score of 0.59. This is a bad value and indicates that IX is not financially healthy and even has some risk of bankruptcy.
IX has a Altman-Z score (0.59) which is in line with its industry peers.
IX has a Debt/Equity ratio of 1.54. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.54, IX is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Altman-Z 0.59
ROIC/WACC0.8
WACC3.67%
IX Yearly LT Debt VS Equity VS FCFIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2T 4T

2.3 Liquidity

A Current Ratio of 0.50 indicates that IX may have some problems paying its short term obligations.
IX has a worse Current ratio (0.50) than 66.00% of its industry peers.
A Quick Ratio of 0.44 indicates that IX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.44, IX is doing worse than 66.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.44
IX Yearly Current Assets VS Current LiabilitesIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1T 2T 3T

More info and screens

3

3. Growth

3.1 Past

The earnings per share for IX have decreased strongly by -10.80% in the last year.
IX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.09% yearly.
IX shows a small growth in Revenue. In the last year, the Revenue has grown by 2.15%.
The Revenue has been decreasing by -1.43% on average over the past years.
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%-36.29%
Revenue 1Y (TTM)2.15%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%-7.23%

3.2 Future

Based on estimates for the next years, IX will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.32% on average per year.
IX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.45% yearly.
EPS Next Y25.58%
EPS Next 2Y23.76%
EPS Next 3Y17.35%
EPS Next 5Y15.32%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y6.92%
Revenue Next 5Y6.45%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IX Yearly Revenue VS EstimatesIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1T 2T 3T
IX Yearly EPS VS EstimatesIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100 200 300 400

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.22, which indicates a correct valuation of IX.
IX's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.45, IX is valued a bit cheaper.
The Price/Forward Earnings ratio is 9.28, which indicates a very decent valuation of IX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IX indicates a somewhat cheap valuation: IX is cheaper than 62.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, IX is valued rather cheaply.
Industry RankSector Rank
PE 14.22
Fwd PE 9.28
IX Price Earnings VS Forward Price EarningsIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IX is valued a bit cheaper than 77.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.63
IX Per share dataIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

IX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IX may justify a higher PE ratio.
IX's earnings are expected to grow with 17.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.56
PEG (5Y)N/A
EPS Next 2Y23.76%
EPS Next 3Y17.35%

More info and screens

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.82%, IX has a reasonable but not impressive dividend return.
IX's Dividend Yield is rather good when compared to the industry average which is at 4.97. IX pays more dividend than 82.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, IX pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.82%

5.2 History

The dividend of IX is nicely growing with an annual growth rate of 7.63%!
IX has been paying a dividend for at least 10 years, so it has a reliable track record.
IX has decreased its dividend in the last 3 years.
Dividend Growth(5Y)7.63%
Div Incr Years2
Div Non Decr Years2
IX Yearly Dividends per shareIX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

5.3 Sustainability

IX pays out 38.56% of its income as dividend. This is a sustainable payout ratio.
The dividend of IX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP38.56%
EPS Next 2Y23.76%
EPS Next 3Y17.35%
IX Yearly Income VS Free CF VS DividendIX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200B -200B -400B -600B
IX Dividend Payout.IX Dividend Payout, showing the Payout Ratio.IX Dividend Payout.PayoutRetained Earnings

More info and screens

ORIX - SPONSORED ADR

NYSE:IX (7/3/2025, 7:39:02 PM)

22.89

+0.07 (+0.31%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-12 2025-05-12/dmh
Earnings (Next)08-04 2025-08-04
Inst Owners48.32%
Inst Owner Change404.54%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.02B
Analysts75
Price Target26.48 (15.68%)
Short Float %0.03%
Short Ratio1.43
Dividend
Industry RankSector Rank
Dividend Yield 3.82%
Yearly Dividend0.82
Dividend Growth(5Y)7.63%
DP38.56%
Div Incr Years2
Div Non Decr Years2
Ex-Date03-28 2025-03-28 (57.84)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.62%
Min EPS beat(2)-26.43%
Max EPS beat(2)-6.82%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.83%
Min Revenue beat(2)-9.12%
Max Revenue beat(2)-8.55%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.57%
PT rev (3m)1.03%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)-0.17%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)0.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.38%
Valuation
Industry RankSector Rank
PE 14.22
Fwd PE 9.28
P/S 1.3
P/FCF N/A
P/OCF 2.88
P/B 0.92
P/tB 0.92
EV/EBITDA 8.63
EPS(TTM)1.61
EY7.03%
EPS(NY)2.47
Fwd EY10.78%
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)7.95
OCFY34.72%
SpS17.57
BVpS25
TBVpS25
PEG (NY)0.56
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.08%
ROE 8.6%
ROCE 4.22%
ROIC 2.94%
ROICexc 3.26%
ROICexgc 4.49%
OM 19%
PM (TTM) 12.23%
GM 42.41%
FCFM N/A
ROA(3y)2.03%
ROA(5y)1.94%
ROE(3y)8.52%
ROE(5y)8.3%
ROIC(3y)2.75%
ROIC(5y)2.57%
ROICexc(3y)3.03%
ROICexc(5y)2.82%
ROICexgc(3y)4.05%
ROICexgc(5y)3.82%
ROCE(3y)3.94%
ROCE(5y)3.67%
ROICexcg growth 3Y6.88%
ROICexcg growth 5Y4.08%
ROICexc growth 3Y6.77%
ROICexc growth 5Y3.25%
OM growth 3Y3.42%
OM growth 5Y1.44%
PM growth 3Y-0.42%
PM growth 5Y-1.63%
GM growth 3Y3.87%
GM growth 5Y1.83%
F-Score5
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF N/A
Debt/EBITDA 6.64
Cap/Depr 339.82%
Cap/Sales 47.23%
Interest Coverage 250
Cash Conversion 137.5%
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.44
Altman-Z 0.59
F-Score5
WACC3.67%
ROIC/WACC0.8
Cap/Depr(3y)325.04%
Cap/Depr(5y)298.28%
Cap/Sales(3y)43.48%
Cap/Sales(5y)39.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.8%
EPS 3Y-0.85%
EPS 5Y-1.09%
EPS Q2Q%-36.29%
EPS Next Y25.58%
EPS Next 2Y23.76%
EPS Next 3Y17.35%
EPS Next 5Y15.32%
Revenue 1Y (TTM)2.15%
Revenue growth 3Y5.32%
Revenue growth 5Y-1.43%
Sales Q2Q%-7.23%
Revenue Next Year10.87%
Revenue Next 2Y7.75%
Revenue Next 3Y6.92%
Revenue Next 5Y6.45%
EBIT growth 1Y-4.51%
EBIT growth 3Y8.05%
EBIT growth 5Y6.26%
EBIT Next Year11292.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-235.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.57%
OCF growth 3Y5.62%
OCF growth 5Y4.52%